|
⚲
|
| Keyboard |
| Icahn School of Medicine at Mount Sinai
✚
|
|
|---|---|
| CIK # | 0001883139 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001883139] | |
| 4 | [0001883139] | |
| SC 13D | [0001883139] | |
| SC 13G | [0001883139] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Mount Sinai Health System Inc | |
| Icahn School of Medicine at Mount Sinai | |
| GeneDx Holdings Corp | |
| Mount Sinai Hospitals Group Inc | |
| Renalytix PLC | |
| Mount Sinai Hospital |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
GeneDx Holdings Corp WGS
Class A Common Stock
|
2024-11-18 | Sell | 126,782 | $70.78 | 8,973,630 |
|
GeneDx Holdings Corp WGS
Class A Common Stock
|
2024-11-15 | Sell | 20,359 | $69.78 | 1,420,651 |
|
Renalytix PLC RNLX
Ordinary Shares
|
2024-11-01 | Other | 13,366,750 | $0.12 | 1,604,010 |
|
GeneDx Holdings Corp WGS
Class A Common Stock
|
2024-10-31 | Sell | 865,800 | $75.00 | 64,935,000 |
|
Renalytix PLC RNLX
Ordinary Shares
|
2024-04-24 | Other | 9,360,374 | $0.25 | 2,340,094 |
|
GeneDx Holdings Corp WGS
Class A Common Stock
|
2023-01-31 | Buy | 28,571,428 | $0.35 | 10,000,000 |
|
GeneDx Holdings Corp SMFR
Class A Common Stock
|
2022-04-29 | Buy | 6,250,000 | $4.00 | 25,000,000 |